Andrea Dahle-Morville

Andrea Dahle-Morville has extensive work experience in the pharmaceutical industry, with a focus on drug substance production, quality management, and process optimization. Andrea'smost recent role is at Bavarian Nordic, where they are the Head of Drug Substance, overseeing a large team and managing vaccine production. Prior to this, they worked at Xellia Pharmaceuticals in various leadership positions, including Head of Final Handling, Head of Global Quality Operational Excellence, and Head of Quality for Finished Products. Andrea also has experience at Novo Nordisk A/S as an Associate Manager in FlexPen® assembly production and as a Lean Manufacturing Consultant. In addition, they have a background in engineering and completed a project at TOP-TOY A/S focused on warehouse management and logistics. Overall, Andrea Dahle-Morville has a strong track record of leading teams, improving processes, and ensuring high-quality standards in pharmaceutical manufacturing.

Andrea Dahle-Morville attended Copenhagen University College of Engineering from 2005 to 2009, where they obtained a degree in Production Engineering. During their time at the university, they focused on studying production and process optimization, as well as management, economics, law, and strategy.